Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Insulin Resistance × Breast × Clear all

Phase

Status

Sponsor Class

OTHER 6 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2 Genitourinary 1 Gastrointestinal 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 242 Triple Negative Breast Neoplasms 17 Neoplasms 8 Motor Activity 8 Breast Cancer Female 8 Lymphedema 7 Breast Cancer Lymphedema 7 Pathologic Complete Response 6 Neoplasm Metastasis 5 Fatigue 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Pain, Postoperative 4 Pain 4 Stomach Neoplasms 3 Radiodermatitis 3 Hereditary Breast and Ovarian Cancer Syndrome 3 Endometrial Neoplasms 3 Thyroid Neoplasms 2 Seroma 2 Recurrence 2 Radiation Injuries 2 Melanoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Breast Cancer 2 HER2 Positive Metastatic Breast Cancer 2 HER2 Positive Breast Cancer 2 Fatigue Syndrome, Chronic 2 Drug-Related Side Effects and Adverse Reactions 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03886389 2019-05-13

BCDIS

Helse Stavanger HF

Phase NA Completed

Breast Neoplasms, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡